Company Description

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expert-based contract research, consulting, medical communications, and technology solutions to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the devel... More >>

Q4 2016 Quarterly Results (Final)More Info >>
 Form 10-K
 Form 8-K
Q4 Financial Results and Trended Information
Q4 2016 Quarterly Results (Preliminary)More Info >>
Earnings Press Release
 Form 8-K
Q4 Financial Results and Trended Information

Recent NewsMore Info >>
9/26/16
PAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm
9/19/16
Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting
9/1/16
PAREXEL International to Present at Wells Fargo Healthcare Conference

EventsMore Info >>
PAREXEL International Investor Day 2016
Thursday, June 30, 2016 9:00 a.m. ET
Supporting Materials
Download Event Supporting Material PAREXEL’s 2016 Investor Day Presentation